Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biohaven Pharmaceutical Holding Company Ltd (NY: BHVN )

83.15 USD -2.60 (-3.03%)
Official Closing Price Updated: 6:30 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 435,144
Open 85.75
Bid (Size) 75.00 (2)
Ask (Size) 83.86 (1)
Prev. Close 85.75
Today's Range 81.74 - 88.28
52wk Range 26.56 - 100.77
Shares Outstanding 36,017,573
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biohaven To Report Fourth Quarter And Full Year 2020 Financial Results And Recent Business Developments On March 1, 2021
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and... 
From PR Newswire
Biohaven's BHV-1200, A Multimodal Antibody Therapy Enhancer (MATE), Demonstrates Effective Neutralization Of Multiple Strains Of COVID-19
-Biohaven's proprietary MATE™ conjugation platform has been used to generate a new class of antibody-based therapies to target COVID-19 
From PR Newswire

Performance

YTD
+1.51%
+1.51%
1 Month
-3.83%
-3.83%
3 Month
-7.22%
-7.22%
6 Month
+36.76%
+36.76%
1 Year
+89.84%
+89.84%

More News

Read More
Biohaven Provides Update On ESG Practices
From PR Newswire
Biohaven Announces Preliminary 4Q2020 Net Product Revenue For NURTEC® ODT
From PR Newswire
Biohaven Signs Cody Ware as Driver for Nurtec® ODT Chevrolet for the 2021 NASCAR Cup Series Season
From PR Newswire
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team
From Business Wire News Releases
Biohaven Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program
From PR Newswire
Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs
From PR Newswire
Biohaven's Nurtec® ODT Partners with Rick Ware Racing for 24 Hours of Daytona Entry
From PR Newswire
Biohaven Pharma's BHV-1200 Effective In Neutralizing COVID-19 Variants
Tags Benzinga General Bill Gates
From Benzinga
Biohaven Begins Pivotal Phase 3 Trial Of Troriluzole In Obsessive-Compulsive Disorder
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]